Literature DB >> 22629472

Amygdala 14-3-3ζ as a novel modulator of escalating alcohol intake in mice.

Heidi M B Lesscher1, Julia M Houthuijzen, Marian J Groot Koerkamp, Frank C P Holstege, Louk J M J Vanderschuren.   

Abstract

Alcoholism is a devastating brain disorder that affects millions of people worldwide. The development of alcoholism is caused by alcohol-induced maladaptive changes in neural circuits involved in emotions, motivation, and decision-making. Because of its involvement in these processes, the amygdala is thought to be a key neural structure involved in alcohol addiction. However, the molecular mechanisms that govern the development of alcoholism are incompletely understood. We have previously shown that in a limited access choice paradigm, C57BL/6J mice progressively escalate their alcohol intake and display important behavioral characteristic of alcohol addiction, in that they become insensitive to quinine-induced adulteration of alcohol. This study used the limited access choice paradigm to study gene expression changes in the amygdala during the escalation to high alcohol consumption in C57BL/6J mice. Microarray analysis revealed that changes in gene expression occurred predominantly after one week, i.e. during the initial escalation of alcohol intake. One gene that stood out from our analysis was the adapter protein 14-3-3ζ, which was up-regulated during the transition from low to high alcohol intake. Independent qPCR analysis confirmed the up-regulation of amygdala 14-3-3ζ during the escalation of alcohol intake. Subsequently, we found that local knockdown of 14-3-3ζ in the amygdala, using RNA interference, dramatically augmented alcohol intake. In addition, knockdown of amygdala 14-3-3ζ promoted the development of inflexible alcohol drinking, as apparent from insensitivity to quinine adulteration of alcohol. This study identifies amygdala 14-3-3ζ as a novel key modulator that is engaged during escalation of alcohol use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22629472      PMCID: PMC3358291          DOI: 10.1371/journal.pone.0037999

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  79 in total

Review 1.  Review. Evidence-based treatments of addiction.

Authors:  Charles P O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 2.  The science of making drug-addicted animals.

Authors:  S H Ahmed
Journal:  Neuroscience       Date:  2011-08-10       Impact factor: 3.590

3.  Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol.

Authors:  R L Bell; M W Kimpel; Z A Rodd; W N Strother; F Bai; C L Peper; R D Mayfield; L Lumeng; D W Crabb; W J McBride; F A Witzmann
Journal:  Alcohol       Date:  2006-08       Impact factor: 2.405

4.  Association between alcoholism and the genetic polymorphisms of the GABAA receptor genes on chromosome 5q33-34 in Korean population.

Authors:  Chul-Soo Park; So-Young Park; Chul-Soon Lee; Jin-Wook Sohn; Gyu-Hee Hahn; Bong-Jo Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

5.  Allelic and haplotypic association of GABRA2 with alcohol dependence.

Authors:  Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

6.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

7.  Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons.

Authors:  Marisa Roberto; Samuel G Madamba; Scott D Moore; Melanie K Tallent; George R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

8.  Long-term ethanol self-administration by the nonhuman primate, Macaca fascicularis, decreases the benzodiazepine sensitivity of amygdala GABA(A) receptors.

Authors:  Nancy J Anderson; James B Daunais; David P Friedman; Kathleen A Grant; Brian A McCool
Journal:  Alcohol Clin Exp Res       Date:  2007-04-11       Impact factor: 3.455

Review 9.  Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems.

Authors:  B J Everitt; J A Parkinson; M C Olmstead; M Arroyo; P Robledo; T W Robbins
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

10.  14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Ss Chauhan; Kw Michael Siu; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

View more
  5 in total

1.  A single alcohol drinking session is sufficient to enable subsequent aversion-resistant consumption in mice.

Authors:  Kelly Lei; Scott A Wegner; Ji-Hwan Yu; Jeffrey A Simms; F Woodward Hopf
Journal:  Alcohol       Date:  2016-08-20       Impact factor: 2.405

2.  Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice.

Authors:  Kelly Lei; Scott A Wegner; Ji-Hwan Yu; F Woodward Hopf
Journal:  Neuropharmacology       Date:  2016-08-11       Impact factor: 5.250

3.  Alcohol-preferring P rats exhibit aversion-resistant drinking of alcohol adulterated with quinine.

Authors:  Nicholas M Timme; David Linsenbardt; Maureen Timm; Taylor Galbari; Ethan Cornwell; Christopher Lapish
Journal:  Alcohol       Date:  2019-09-19       Impact factor: 2.405

Review 4.  Rodent models for compulsive alcohol intake.

Authors:  F Woodward Hopf; Heidi M B Lesscher
Journal:  Alcohol       Date:  2014-03-27       Impact factor: 2.405

5.  Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study.

Authors:  Joanna M Biernacka; Brandon J Coombes; Anthony Batzler; Ada Man-Choi Ho; Jennifer R Geske; Josef Frank; Colin Hodgkinson; Michelle Skime; Colin Colby; Lea Zillich; Sofia Pozsonyiova; Ming-Fen Ho; Falk Kiefer; Marcella Rietschel; Richard Weinshilboum; Stephanie S O'Malley; Karl Mann; Ray Anton; David Goldman; Victor M Karpyak
Journal:  Neuropsychopharmacology       Date:  2021-07-23       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.